A detailed history of Algert Global LLC transactions in Cerus Corp stock. As of the latest transaction made, Algert Global LLC holds 75,196 shares of CERS stock, worth $134,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,196
Previous 55,086 36.51%
Holding current value
$134,600
Previous $97,000 35.05%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.7 - $2.39 $34,187 - $48,062
20,110 Added 36.51%
75,196 $131,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $89,239 - $112,375
55,086 New
55,086 $97,000
Q4 2023

Feb 14, 2024

SELL
$1.25 - $2.35 $588,902 - $1.11 Million
-471,122 Reduced 79.43%
121,970 $263,000
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.07 $106,530 - $218,031
71,020 Added 13.6%
593,092 $961,000
Q2 2023

Aug 14, 2023

SELL
$1.79 - $2.9 $255,722 - $414,299
-142,862 Reduced 21.49%
522,072 $1.28 Million
Q1 2023

May 12, 2023

BUY
$2.65 - $3.81 $1.36 Million - $1.96 Million
514,184 Added 341.08%
664,934 $1.98 Million
Q4 2022

Feb 13, 2023

SELL
$3.38 - $4.22 $382,075 - $477,028
-113,040 Reduced 42.85%
150,750 $550,000
Q3 2022

Nov 15, 2022

BUY
$3.43 - $5.83 $12,972 - $22,049
3,782 Added 1.45%
263,790 $950,000
Q2 2022

Aug 15, 2022

BUY
$4.41 - $5.69 $22,050 - $28,450
5,000 Added 1.96%
260,008 $1.38 Million
Q1 2022

May 16, 2022

BUY
$4.81 - $6.99 $979,594 - $1.42 Million
203,658 Added 396.61%
255,008 $1.4 Million
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $306,559 - $407,205
51,350 New
51,350 $350,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.